15M in the US seeking solutions for knee pain and dysfunction + 1M recovering from knee surgery  ~$10B knee treatment TAM. Poor quadriceps muscle strength correlates with pain, poor mobility, and lower quality of life, creating $3B in avoidable healthcare spend. Physical therapy is effective, but <30% of patients attend all prescribed sessions or remain compliant with their home-based regimens. COVID-19 has driven physical therapy cancellations and no-shows up by 20% and delayed ~10k knee procedures per lockdown week, creating more need for cost- and time-efficient, remote, trackable rehab.

* Raised $750,000+ to date through awards, accelerators, and angels
* Secured $1.3M award from U.S. Army / MTEC to fund clinical trial at West Point
* Developed working prototypes; refined to pre-submission stage
* Completed proof-of-concept studies demonstrating high accuracy in stim timing and location + positive trends toward relieving pain and improving mobility
* Market interest validated with prescribers, users; 65% of interviewed prescribers are interested or highly interested in offering KneeStim to 30-50% of their patient base
* Coverage/CMS codes identified for in-clinic use, device rental, and remote monitoring
* Four US utility patents granted
* LOIs w/two hospital networks
* Awards won through AngelMD, OrthoChallenge, and IoT/WT Innovation World Cup